Work

Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa

Year: 2025

Type: article

Study design: Observational Study

Source: American Journal of Ophthalmology

DOI: 10.1016/j.ajo.2025.06.031

Authors: MAXIMILIAN D. KONG, JOHNATHAN A. BAILEY, ABDHEL EXINOR, NOAH HEAPS, JIMMY DUONG, BAICHUN HOU, CHANAKARN PIAMJITCHOL, AYKUT DEMIRKOL, SCOTT E. BRODIE, JANET R. SPARROW, STEPHEN H. TSANG

Institutions: State University of New York, NewYork–Presbyterian Hospital, SUNY Downstate Health Sciences University, Columbia University Irving Medical Center, Columbia University, Bumrungrad International Hospital

Language: English

Topic: Retinal Development and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Foundation Fighting Blindness, Research to Prevent Blindness, New York Eye and Ear Infirmary of Mount Sinai, Abeona Therapeutics, National Institutes of Health, National Eye Institute

Awards: G6382212690, Translational Gene Therapy for CNGB1 Retinitis Pigmentosa, G9000072492, G9000120498, G9000313720, Defining Barriers to Gene Therapy, Gene Editing and Silencing in Phototransduction

OpenAlex ID: W4411635106

FWCI: 1.204

Cites: 33

Cited by: 4

Related to: 10